ID

35750

Descripción

Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01867502

Link

https://clinicaltrials.gov/show/NCT01867502

Palabras clave

Versiones (1)
  1. 20/3/19 20/3/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de marzo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT01867502

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT01867502

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Glucose measurement, fasting

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0202045
recent hba1c determination (between 7, 5 and 10%);
Descripción

Hemoglobin A1c measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474680
not involved in regular physical exercise;
Descripción

Absence Involvement with Exercise Regular

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0015259
UMLS CUI [1,4]
C0205272
older than 18 years;
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
in use of metformin.
Descripción

Metformin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025598
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
smoker and use of analgesic or anti-inflammatory drugs during the week of the study
Descripción

Tobacco use | Analgesics | Anti-Inflammatory Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543414
UMLS CUI [2]
C0002771
UMLS CUI [3]
C0003209
bmi > 40 kg/m²;
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
proliferative retinopathy;
Descripción

Proliferative retinopathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0339467
ischemic cardiomyopathy;
Descripción

Ischemic cardiomyopathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0349782
peripheral vascular disease;
Descripción

Peripheral Vascular Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085096
blood aspartate transaminase (ast) and alanine transaminase (alt) 2.5 times higher the normal concentration before screening visit
Descripción

Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
lactose intolerance;
Descripción

Lactose Intolerance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022951
renal insufficiency (creatinine clearance <60ml/min);
Descripción

Renal Insufficiency | Creatinine clearance measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0373595
blood pressure more than 180/100mmhg at rest (3 consecutive measures).
Descripción

Blood pressure determination At rest | Measurement Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005824
UMLS CUI [1,2]
C0443144
UMLS CUI [2,1]
C0242485
UMLS CUI [2,2]
C1265611
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01867502

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Glucose measurement, fasting
Item
type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
boolean
C0011860 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
Hemoglobin A1c measurement
Item
recent hba1c determination (between 7, 5 and 10%);
boolean
C0474680 (UMLS CUI [1])
Absence Involvement with Exercise Regular
Item
not involved in regular physical exercise;
boolean
C0332197 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0015259 (UMLS CUI [1,3])
C0205272 (UMLS CUI [1,4])
Age
Item
older than 18 years;
boolean
C0001779 (UMLS CUI [1])
Metformin
Item
in use of metformin.
boolean
C0025598 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Tobacco use | Analgesics | Anti-Inflammatory Agents
Item
smoker and use of analgesic or anti-inflammatory drugs during the week of the study
boolean
C0543414 (UMLS CUI [1])
C0002771 (UMLS CUI [2])
C0003209 (UMLS CUI [3])
Body mass index
Item
bmi > 40 kg/m²;
boolean
C1305855 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy;
boolean
C0339467 (UMLS CUI [1])
Ischemic cardiomyopathy
Item
ischemic cardiomyopathy;
boolean
C0349782 (UMLS CUI [1])
Peripheral Vascular Disease
Item
peripheral vascular disease;
boolean
C0085096 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
blood aspartate transaminase (ast) and alanine transaminase (alt) 2.5 times higher the normal concentration before screening visit
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Lactose Intolerance
Item
lactose intolerance;
boolean
C0022951 (UMLS CUI [1])
Renal Insufficiency | Creatinine clearance measurement
Item
renal insufficiency (creatinine clearance <60ml/min);
boolean
C1565489 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Blood pressure determination At rest | Measurement Quantity
Item
blood pressure more than 180/100mmhg at rest (3 consecutive measures).
boolean
C0005824 (UMLS CUI [1,1])
C0443144 (UMLS CUI [1,2])
C0242485 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial